Health Canada approves Johnson & Johnson vaccine made in Baltimore

OTTAWA – Health Canada gives the green light for the use of the Johnson & Johnson (J&J) COVID-19 vaccine manufactured at Emergent BioSolutions in Baltimore, Maryland. However, no delivery of doses would be planned for the moment in the country.

Last summer, Canada rejected hundreds of thousands of doses of the vaccine made at the US plant. Only doses manufactured in Europe of the vaccine marketed under the name “Janssen” were approved by Health Canada.

But following an on-site inspection of the Emerging BioSolutions facility in Baltimore, Health Canada and its partners the European Medicines Agency and the South African regulatory authority concluded that “the facility is compliant. to good manufacturing practices ”.

This means that the Janssen vaccine can be imported into Canada and used to inoculate Canadians.

“There are no further shipments of the Janssen vaccine to be expected at this time, but the Government of Canada continues to work with its provincial and territorial partners to assess the need for additional doses of this vaccine,” he said. federal agency by means of a press release.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.